<?xml version="1.0" encoding="UTF-8"?>
<ref id="ppat.1008393.ref083">
 <label>83</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>de Vries</surname>
   <given-names>R</given-names>
  </name>, 
  <name>
   <surname>Rimmelzwaan</surname>
   <given-names>G</given-names>
  </name>. 
  <article-title>Viral vector-based influenza vaccines.</article-title>
  <source>Human Vaccines &amp; Immunotherapeutics</source>. 
  <year>2016</year>;
  <volume>12</volume>(
  <issue>11</issue>):
  <fpage>2881</fpage>â€“
  <lpage>2901</lpage>. 
  <pub-id pub-id-type="doi">10.1080/21645515.2016.1210729</pub-id> .
  <?supplied-pmid 27455345?>
  <pub-id pub-id-type="pmid">27455345</pub-id>
 </mixed-citation>
</ref>
